JPH0314512A - Oral cavity composition for suppressing deposition of dental plaque - Google Patents

Oral cavity composition for suppressing deposition of dental plaque

Info

Publication number
JPH0314512A
JPH0314512A JP14905889A JP14905889A JPH0314512A JP H0314512 A JPH0314512 A JP H0314512A JP 14905889 A JP14905889 A JP 14905889A JP 14905889 A JP14905889 A JP 14905889A JP H0314512 A JPH0314512 A JP H0314512A
Authority
JP
Japan
Prior art keywords
oral cavity
polymer
dental plaque
formula
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP14905889A
Other languages
Japanese (ja)
Other versions
JP2760573B2 (en
Inventor
Tomoko Katsuta
勝田 倫子
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunstar Inc
Original Assignee
Sunstar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunstar Inc filed Critical Sunstar Inc
Priority to JP1149058A priority Critical patent/JP2760573B2/en
Publication of JPH0314512A publication Critical patent/JPH0314512A/en
Application granted granted Critical
Publication of JP2760573B2 publication Critical patent/JP2760573B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PURPOSE:To provide an oral cavity composition containing a specific polymer, effective in suppressing the deposition of dental plaque and useful for the prevention of dental caries and periodontosis. CONSTITUTION:A composition for oral cavity application containing 0.001-10wt.% of a polymer having a recurring unit expressed by formula (R1 and R2 are 1-10C lower alkyl; n is a number corresponding to an average molecular weight of 50,000-500,000) is properly compounded with conventional abrasive, wetting agent, foaming agent, preservative, flavor, drug-active component, etc., and formed by conventional process to obtain the objective composition. It can be prepared in the form of tooth paste, tooth powder, liquid dentifrice, wet dentifrice, mouth wash, etc. An example of the polymer of formula is poly(methylvinyl ether/maleic acid) monoethyl ester, which is commercially available as Gantrez ES-225 (product of GAF Chemicals Inc.).

Description

【発明の詳細な説明】 産業上の利用分野 本発明は歯垢の付着を抑制し、う蝕や歯周病を予防する
歯磨のような口腔用組底物に関する。
DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to an oral implant such as a toothpaste that suppresses the adhesion of dental plaque and prevents caries and periodontal disease.

従来の技術および課題 う蝕や歯周病は、口腔細菌の増殖により生じる歯垢か原
因で発症することか明らかにされている。
Conventional techniques and problems It has been clarified that caries and periodontal disease are caused by dental plaque caused by the proliferation of oral bacteria.

すなわち、う蝕は歯垢中のストレプトコノカス・ミュー
タンス等のある種の細菌が糖を代謝して生じる酸が歯牙
のエナメル質を脱灰することによりひきおこされる。ま
た、歯垢中のある種の細菌は歯茎を刺激する酵素と内毒
素とを分泌し、歯茎に炎症をひきおこし、そのため歯茎
は出血しゃすくなり、弾力性を失い、歯から離れるよう
になり、歯周ボケノトを生じる。この歯周ボケノトが嫌
気性細菌の住処となり、それらの代謝物により歯周組織
が破壊され、歯周病がひきおこされる。
That is, caries is caused by the acid produced when certain bacteria such as Streptoconoccus mutans in dental plaque metabolize sugar and demineralize tooth enamel. Also, certain bacteria in plaque secrete enzymes and endotoxins that irritate the gums, causing inflammation of the gums, which causes them to bleed easily, lose elasticity, and pull away from the teeth. This causes periodontal blur. This periodontal pocket becomes a home for anaerobic bacteria, and their metabolites destroy the periodontal tissue, causing periodontal disease.

そこで、従来から、う蝕や歯周病の予防のために歯垢の
付着を抑制する種々の方法や物質が提案されている。し
かしながら、十分に満足するものでは未だ見当たらない
Therefore, various methods and substances have been proposed to suppress the adhesion of dental plaque in order to prevent dental caries and periodontal disease. However, nothing that is fully satisfactory has yet been found.

このような現状に鑑み、本発明者らは歯垢の付着抑制に
ついて種々検討したところ、意外にも、ある種のボリマ
ーが優れた歯垢付着抑制効果を有し、歯磨のような口腔
用組成物の歯垢付着抑制剤として有用であることを見出
した。
In view of this current situation, the present inventors conducted various studies on suppressing the adhesion of dental plaque, and surprisingly found that certain polymers have an excellent effect of suppressing the adhesion of dental plaque, and that they can be used in oral compositions such as toothpaste. It has been found that it is useful as an agent for inhibiting plaque adhesion on objects.

ある種のポリマーを口腔用組戊物に処方することは従来
から知られており、例えば、米国特許第4,303,7
66号は、予め歯に適用された薬剤の歯からの溶出を防
止する膜形代用に分子量2000〜4,000,000
のポリアクリル酸フボリマーを処方した歯磨組戊物を開
示している。また、特開昭61−165317号は平均
分子量3,500〜7.500のポリアクリル酸ボリマ
ーあるいはコポリマーを抗歯石剤として口腔用組或物に
処方することを開示している。さらに、特開昭63−3
3321号はアクリル酸コボリマーを処方した口腔用組
戊物がフソ化物の歯エナメル質への吸収を促進すること
を開示している。
It has been known for some time to formulate certain polymers into oral compositions, e.g., U.S. Pat. No. 4,303,7.
No. 66 is a film substitute with a molecular weight of 2000 to 4,000,000 that prevents the elution of a drug applied to the teeth from the teeth.
Discloses a toothpaste composition formulated with polyacrylic acid fuborimer. Furthermore, JP-A-61-165317 discloses the formulation of polyacrylic acid polymers or copolymers having an average molecular weight of 3,500 to 7,500 in oral cavity compositions as anti-calculus agents. Furthermore, JP-A-63-3
No. 3321 discloses that oral compositions formulated with acrylic acid cobolimers promote the absorption of fusodide into tooth enamel.

しかしながら、これらのボリマーは歯垢の付着を抑制す
るものではない。
However, these polymers do not inhibit plaque adhesion.

課題を解決するための手段 本発明は、式: [1] E式中、R1およびR,は同一または異なって、各々、
炭素数1〜10の低級アルキル、nは平均分子量が50
,000〜5 0 0, 0 00となるような数を意
味する〕 で示される繰り返し単位を有するボリマーを歯垢付着抑
制剤として含有することを特徴とする歯垢付着抑制口腔
用組戊物を提供するものである。
Means for Solving the Problems The present invention provides the formula: [1] E, in which R1 and R are the same or different, and each
Lower alkyl having 1 to 10 carbon atoms, n is an average molecular weight of 50
,000 to 500,000] A plaque adhesion inhibiting oral cavity composition characterized by containing a polymer having a repeating unit represented by the following as a plaque adhesion inhibitor. This is what we provide.

本発明で歯垢付着抑制剤として用いるコボリマーの式[
1〕で示される繰り返し単位におけるR,およびR,の
アルキルとしてはメチル、エチル、プロビル、ブチル、
ベンチル、ヘキシルなどが挙げられ、R1としては、特
に、メチルが好ましい。
The formula of cobolimer used as a plaque adhesion inhibitor in the present invention [
In the repeating unit represented by 1], R and the alkyl of R include methyl, ethyl, proyl, butyl,
Bentyl, hexyl, etc. are mentioned, and R1 is particularly preferably methyl.

平均分子量は約50,000〜500,000程度のも
のが好ましい。式[1]の繰り返し単位を有するポリマ
ーの代表的なものとしてはR,がメチル、R2がエチル
、イソブロビルまたはブチルのちの、すなわち、ポリ(
メチルビニルエーテル/マレイン酸)のモノエチルー、
モノイソブロピルーまたはモノブチルエステルが挙げら
れ、これらは、各々、ガントレノツES−225、ES
−335、ES−425およびES−435の商品名で
知られるボリマーで、ガフ・ケミカルズ社(GAFCH
MICALS)より商業的に人手できる。これらのポワ
マーは歯垢付着抑制効果の観点から、一般に、口腔用組
戊物にたいして0.001〜10重量%の割合で処方さ
れる。
The average molecular weight is preferably about 50,000 to 500,000. Typical examples of polymers having repeating units of formula [1] include R, methyl, R2, ethyl, isobrobyl, or butyl, that is, poly(
monoethyl of methyl vinyl ether/maleic acid),
monoisopropyl or monobutyl esters, which are Gantorenotsu ES-225, ES
-335, ES-425 and ES-435 are polymers manufactured by Gaff Chemicals (GAFCH).
MICALS) is more commercially available. These poamers are generally formulated in an amount of 0.001 to 10% by weight based on the oral cavity composition from the viewpoint of inhibiting plaque adhesion.

本発明の口腔用組戊物は公知の方注に従って練歯磨、粉
歯磨、1夜状歯磨、潤製歯磨、洗口剤などの剤形とする
ことができ、他の配合成分は特に限定するものではなく
、公知の研磨剤、湿潤剤、発泡剤、保存剤、香料、薬効
剤などが適宜処方できる。
The oral composition of the present invention can be made into a dosage form such as a toothpaste, powdered toothpaste, overnight toothpaste, moisturized toothpaste, mouthwash, etc. according to known instructions, and other ingredients are not particularly limited. However, known abrasives, wetting agents, foaming agents, preservatives, fragrances, medicinal agents, etc. can be appropriately formulated.

実施例 つぎに実験例および実施例を挙げて本発明をさらに詳し
く説明する。
EXAMPLES Next, the present invention will be explained in more detail with reference to experimental examples and examples.

実験例1 唾肢被覆ヒドロキノアパタイト(}{AP)ビーズ上へ
のストレブトコノカス・ミュータンス6715の吸着に
及ぼす効果 (1)20xtのHAPビーズをヒトの唾液(血液型○
)O.Eljとともに室温にて1時間インキユベートし
た。該ビーズを0.05M  KCQ,lmM  PO
.、lmM  CaCILおよひ1mMMgCQ,から
なるpH6.0の緩衝l夜1ffl2で2回洗浄した。
Experimental Example 1 Effect on adsorption of Strebutochonoccus mutans 6715 onto salivary limb-coated hydroquinoapatite (}{AP) beads (1) 20xt HAP beads were mixed with human saliva (blood type ○
)O. Incubated with Elj for 1 hour at room temperature. The beads were mixed with 0.05M KCQ, 1mM PO.
.. , 1 mM CaCIL and 1 mM MgCQ, pH 6.0 buffer, and washed twice with 1 ffl2.

(この緩衝液は、唾液無機成分に似せたものである)。(This buffer mimics the inorganic components of saliva).

次いで、室温にて、該ビーズをpH70の試料溶液o.
szcとともに1時間インキユベートシ、上記緩衝液1
村で2回洗浄した。
The beads were then added to a pH 70 sample solution o.
Incubate for 1 hour with szc, buffer 1 above.
I washed it twice in the village.

次に、前記緩衝液0.5xI2中に[3H]チミジン標
識バクテリア(ストレプトコノカス・ミュータンス)を
5.OX10’個含むせ濁l夜を該ビーズに添加し、室
温にて1時間インキユベートした。前記緩衝液1村で3
回洗浄し、ビーズをバイアルに移し、液体シンチレーン
ヨンカウンターを用いて放射能を計副した。一方、既知
のc’H]t=識細胞の割合を同し方法で計数し、バク
テリア数の検量線を作戊した。
Next, [3H]thymidine-labeled bacteria (Streptoconoccus mutans) was added to the buffer 0.5xI2 for 5 minutes. A suspension containing 10' OX was added to the beads and incubated for 1 hour at room temperature. 3 in 1 village of the buffer solution
After washing twice, the beads were transferred to a vial and radioactivity was counted using a liquid scintillation counter. On the other hand, the known c'H]t=percentage of sensitive cells was counted using the same method, and a calibration curve for the number of bacteria was created.

用いた試料溶液を第1表の唾液彼覆HAPの処理の欄に
示す。
The sample solutions used are shown in the column of salivary HAP treatment in Table 1.

1%共重合体水溶液(ガントレソツES225)は、バ
クテリアの唾液被覆HAPへの吸着を著しく抑制したこ
とが確認された。
It was confirmed that the 1% copolymer aqueous solution (Gantresotsu ES225) significantly suppressed the adsorption of bacteria to saliva-coated HAP.

実験例2 ビーグル犬での該ポリマーの歯垢抑制、歯肉炎抑制効果 20匹のビーグル犬の歯垢および歯石を完全に除去し、
4週間ソフトな飲食物を与えた。このうち10匹を第1
群とし、該ポリマーを含有しない蒸留水で以て処理し、
残りのl○匹を、第n群とし、ポリマー(ガントレッッ
ES−225)を含む水溶液で処理しγ二。この処理は
すべての歯へ5〜6ccの試料廖l夜を施用することに
より、1週間に5日、l日に1回行なつい、二重盲検法
を採用した。歯垢および歯肉炎はロー・アンド・シルネ
スの方広 (八eta  Odontologica 
 Scandinavica,  Q 1551〜55
5 (1963))によって評価した。
Experimental Example 2 Plaque and gingivitis inhibiting effects of the polymer on beagle dogs Completely removed plaque and tartar from 20 beagle dogs.
They were fed soft food and drink for 4 weeks. 10 of these are the first
group and treated with distilled water not containing the polymer,
The remaining l○ rats were treated as the nth group and treated with an aqueous solution containing a polymer (Gantret ES-225). This treatment was carried out once a day, 5 days a week, by applying 5 to 6 cc of sample solution to all teeth, and a double-blind method was adopted. Plaque and gingivitis are treated with the help of low and sillness.
Scandinavica, Q 1551-55
5 (1963)).

結果を第2表に示す。The results are shown in Table 2.

巨 鰭 雫 笑 N −3− 窪 一 実施例1 つぎの処方に従い、常法により練歯磨を製造した。giant fin Shizuku lol N -3- Kubo 1 Example 1 A toothpaste was manufactured by a conventional method according to the following recipe.

戊 分          重量% 炭酸カルシウム          50ヒドロキシエ
チルセルロース     l゛′/l/ e  ・ ト
                         
 l 5グリセリン           10ラウリ
ル硫酸ナトリウム       0.5プルロニノク 
           1安息香酸ナトリウム    
     0 2サッカリンナトリウム       
 0.1ガントレノツES−225       1水
酸化ナトリウム          02香料    
   1 精製水               残部実施例2 つぎの処方に従い、常法により練歯磨を製造した。
Weight % Calcium carbonate 50 hydroxyethyl cellulose l゛'/l/e・t
l 5 Glycerin 10 Sodium lauryl sulfate 0.5 Pluroninoc
1 Sodium benzoate
0 2 saccharin sodium
0.1 GANTRENOTS ES-225 1 Sodium hydroxide 02 Fragrance
1 Purified water Remainder Example 2 A toothpaste was manufactured by a conventional method according to the following recipe.

成分     重量% 第二リン酸カルシウム・二水和物  50無水ケイ酸 
             3ソルビット      
       20カルボキシメチルセルロース   
  1ラウロイルサルコシンナトリウム   05ポリ
オキシエチレン硬化ヒマン油   2バラ安息香酸メチ
ル         0.2ステビアエキス     
       0.2ガントレノツES−335   
    3酢酸トフフェロール         0.
5アラントイン             0.5香料
                l精製水     
          残部実施例3 つぎの処方に従い、常法により液状歯磨を製造した。
Ingredients Weight % Dicalcium phosphate dihydrate 50 silicic anhydride
3 sorbitol
20 carboxymethyl cellulose
1 Sodium lauroyl sarcosine 05 Polyoxyethylene hydrogenated human oil 2 Methyl benzoate 0.2 Stevia extract
0.2 Gun Torenotsu ES-335
Tophferol triacetate 0.
5 allantoin 0.5 fragrance l purified water
Remaining Example 3 A liquid toothpaste was manufactured by a conventional method according to the following recipe.

成分     重量% グリセリン           35ブロビレングリ
コール        5ボリアクリル酸ナトリウム 
     3ラウリル硫酸ナトリウム       1
ボリオキ7エチレン硬化ヒマシ油   2サ/カリンナ
トリウム        0.2ガントレノッES−4
25        0.5水酸化ナトリウム    
      0.2香料       l 精製水               残部実施例4 つぎの処方に従い、常法により潤製歯磨を製造した。
Ingredients Weight% Glycerin 35 Brobylene Glycol 5 Sodium polyacrylate
3 Sodium lauryl sulfate 1
Borioki 7 Ethylene Hydrogenated Castor Oil 2 Sa/Karin Sodium 0.2 Gantreno ES-4
25 0.5 Sodium hydroxide
0.2 fragrance 1 purified water remainder Example 4 According to the following formulation, a Junsei toothpaste was produced by a conventional method.

戊分     重盟% 炭酸カルンウム          70ヒドロキシエ
チルセルロース     1ソルビット       
      10グリセリン           1
5ラウリル硫酸ナトリウム       l酢酸トコフ
ェロール         0.5フ,化ナトリウム 
         0・2パラオキシ安息香酸メチル 
     0.1サノカリンナトリウム       
 0.1ガントレノッES−435        0
.1香料       1 精製水               残部実施例5 つぎの処方に従い、常法により洗口剤を製造した。
Bokubun Juumei% Carunium carbonate 70 Hydroxyethyl cellulose 1 Sorbit
10 glycerin 1
5 Sodium lauryl sulfate l Tocopherol acetate 0.5 Sodium lauryl sulfate
0.2 Methyl paraoxybenzoate
0.1 sanocalin sodium
0.1 GANTRENO ES-435 0
.. 1 fragrance 1 purified water remainder Example 5 A mouthwash was manufactured by a conventional method according to the following formulation.

戊分       重量% グリセリン           10ボリオキシエチ
レン硬化ヒマシ油   1エタスール        
     15サッカリンナトリウム        
0.2安息香酸ナトリウム         0.2ガ
ントレノッES−225        1水酸化ナト
リウム          O、4香料       
0.3 精製水               残部発明の効果 本発明によれば、歯垢の付着を効果的に抑制することの
できる、う蝕や歯周病に有用な口腔用組或物が得られる
Bokubun Weight% Glycerin 10 Polyoxyethylene hydrogenated castor oil 1 Etasul
15 Saccharin sodium
0.2 Sodium benzoate 0.2 Gantrenot ES-225 1 Sodium hydroxide O, 4 Fragrance
0.3 Purified Water Residual Effects of the Invention According to the present invention, an oral cavity composition that can effectively suppress the adhesion of dental plaque and is useful for caries and periodontal disease is obtained.

Claims (1)

【特許請求の範囲】[Claims] (1)式: ▲数式、化学式、表等があります▼ [式中、R_1およびR_2は同一または異なって、各
々、炭素数1〜10の低級アルキル、nは平均分子量が
50,000〜500,000となるような数を意味す
る] で示される繰り返し単位を有するポリマーを歯垢付着抑
制剤として含有することを特徴とする歯垢付着抑制口腔
用組成物。
(1) Formula: ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [In the formula, R_1 and R_2 are the same or different, each is a lower alkyl having 1 to 10 carbon atoms, n has an average molecular weight of 50,000 to 500, 000] A dental plaque adhesion-inhibiting oral composition characterized by containing a polymer having a repeating unit represented by the following as a dental plaque adhesion inhibitor.
JP1149058A 1989-06-12 1989-06-12 Oral composition for inhibiting plaque adhesion Expired - Fee Related JP2760573B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1149058A JP2760573B2 (en) 1989-06-12 1989-06-12 Oral composition for inhibiting plaque adhesion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1149058A JP2760573B2 (en) 1989-06-12 1989-06-12 Oral composition for inhibiting plaque adhesion

Publications (2)

Publication Number Publication Date
JPH0314512A true JPH0314512A (en) 1991-01-23
JP2760573B2 JP2760573B2 (en) 1998-06-04

Family

ID=15466751

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1149058A Expired - Fee Related JP2760573B2 (en) 1989-06-12 1989-06-12 Oral composition for inhibiting plaque adhesion

Country Status (1)

Country Link
JP (1) JP2760573B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05186321A (en) * 1991-07-17 1993-07-27 Unilever Nv Oral composition containing phosphopeptide
EP2868311A1 (en) * 2013-10-30 2015-05-06 Henkel AG&Co. KGAA Oral and tooth care and cleaning agents for reducing the subsequent backstaining of teeth
WO2015172922A1 (en) * 2014-05-14 2015-11-19 Henkel Ag & Co. Kgaa Oral and dental hygiene and cleaning agents for reducing tooth discolouration
KR20200093514A (en) 2017-11-30 2020-08-05 라이온 가부시키가이샤 Oral biofilm formation inhibitor and oral composition

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58208210A (en) * 1982-03-24 1983-12-03 コルゲ−ト・パ−モリブ・カンパニ− Peroxydiphosphate blended dentifrice composition
JPS6467412A (en) * 1987-09-07 1989-03-14 Toyota Motor Corp Stabilizer control device

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58208210A (en) * 1982-03-24 1983-12-03 コルゲ−ト・パ−モリブ・カンパニ− Peroxydiphosphate blended dentifrice composition
JPS6467412A (en) * 1987-09-07 1989-03-14 Toyota Motor Corp Stabilizer control device

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05186321A (en) * 1991-07-17 1993-07-27 Unilever Nv Oral composition containing phosphopeptide
EP2868311A1 (en) * 2013-10-30 2015-05-06 Henkel AG&Co. KGAA Oral and tooth care and cleaning agents for reducing the subsequent backstaining of teeth
WO2015172922A1 (en) * 2014-05-14 2015-11-19 Henkel Ag & Co. Kgaa Oral and dental hygiene and cleaning agents for reducing tooth discolouration
KR20200093514A (en) 2017-11-30 2020-08-05 라이온 가부시키가이샤 Oral biofilm formation inhibitor and oral composition

Also Published As

Publication number Publication date
JP2760573B2 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
EP1272152A2 (en) Use of chlorhexidine in the prevention of root caries
US4205061A (en) Oral antimicrobial compositions
JPH09286712A (en) Composition for oral cavity
US4559223A (en) Silver sulfadiazine and/or zinc sulfadiazine-containing toothpaste or oral medicament
JP3022039B2 (en) Oral composition for preventing tooth coloring
EP0976380B1 (en) Method of recalcifying teeth
EP0562668A1 (en) Monirritating antitartar and antiplaque oral compositions
JP2760573B2 (en) Oral composition for inhibiting plaque adhesion
JPH07165544A (en) Composition for oral cavity
JPS61200905A (en) Composition for oral cavity application
JP3558138B2 (en) Liquid oral composition
JP2812496B2 (en) Antiplaque mouthwash
JPH07138139A (en) Composition for oral cavity application
JP2866393B2 (en) Oral composition for inhibiting plaque accumulation
JPH03178926A (en) Composition for oral cavity application
JP3031785B2 (en) Oral composition
JPH04300816A (en) Composition for oral cavity
JPH0826953A (en) Composition for oral cavity
SU715086A1 (en) Toothpaste
US3819826A (en) Composition and means for oral hygiene
JPH07165547A (en) Composition for oral cavity
JPH04120014A (en) Composition for oral cavity
JP2962530B2 (en) Oral composition
JPH03178925A (en) Composition for oral cavity application
JPS63130520A (en) Composition for oral cavity

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees